KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $4.27.

  • Thermo Fisher Scientific's EPS (Weighted Average and Diluted) rose 47.06% to $4.27 in Q3 2025 from the same period last year, while for Sep 2025 it was $17.31, marking a year-over-year increase of 852.66%. This contributed to the annual value of $16.54 for FY2024, which is 705.81% up from last year.
  • Thermo Fisher Scientific's EPS (Weighted Average and Diluted) amounted to $4.27 in Q3 2025, which was up 47.06% from $4.28 recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's EPS (Weighted Average and Diluted) registered a high of $5.88 during Q2 2021, and its lowest value of $3.32 during Q2 2023.
  • Over the past 5 years, Thermo Fisher Scientific's median EPS (Weighted Average and Diluted) value was $4.22 (recorded in 2022), while the average stood at $4.29.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 19847.72% in 2021, then plummeted by 4082.0% in 2023.
  • Thermo Fisher Scientific's EPS (Weighted Average and Diluted) (Quarter) stood at $4.17 in 2021, then fell by 3.84% to $4.01 in 2022, then rose by 4.74% to $4.2 in 2023, then rose by 13.76% to $4.78 in 2024, then fell by 10.63% to $4.27 in 2025.
  • Its EPS (Weighted Average and Diluted) was $4.27 in Q3 2025, compared to $4.28 in Q2 2025 and $3.98 in Q1 2025.